B. Braun’s Aesculap puts nearly $3m into ApiFix

B. Braun’s Aesculap division today invested $2.8 million into ApiFix’s $5 million Series B financing round to help support ApiFix’s minimally invasive, non-fusion spinal implant system designed to treat adolescent idiopathic scoliosis.

The ApiFix device, which won CE Mark clearance for use in the European Union in 2012, is designed to correct adolescent idiopathic scoliosis without the use of fusion to avoid the potential for loss of spine mobility, the company said.

Get the full story at our sister site, Medical Design & Outsourcing.

The post B. Braun’s Aesculap puts nearly $3m into ApiFix appeared first on MassDevice.

from MassDevice http://ift.tt/2gyQqo6